Emigrant Capital is the private equity division of Emigrant Bank that provides long-term equity to middle-market businesses.
Our current portfolio consists of over 15 investments representing in excess of $200 million of invested capital. We make majority or significant minority investments and then work closely with company managements to build value together.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 7, 2019
Frequency Therapeutics
|
Series B | — | Biotechnology | — |
|
Apr 11, 2017
Frequency Therapeutics
|
Series A | $32M | Biotechnology | — |
|
Apr 5, 2008
GroundLink
|
Series A | $20M | Apps | Yes |
|
Oct 23, 2006
Lev Pharmaceuticals
|
Series Unknown | $21M | Biotechnology | — |
|
Sep 10, 2003
Boylan Bottling
|
Series Unknown | — | Consumer Goods | Yes |
Emigrant Capital has had 4 exits. Emigrant Capital most notable exits include Frequency Therapeutics , GroundLink
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Oct 2, 2019 | Frequency Therapeutics | IPO | Biotechnology | Detail |
| Jan 27, 2017 | GroundLink | M&A | Apps | Detail |
| Aug 6, 2010 | Intralinks | M&A | Clinical Trials | Detail |
| Jul 15, 2008 | Lev Pharmaceuticals | M&A | Biotechnology | Detail |